Quantum BioPharma News - September 24, 2026
Quantum BioPharma Jumps 11% on a New CEO Hire — But Can a Licensing Bet Deliver Real Revenue for a $30 Million Company?
Shares of Quantum BioPharma (NASDAQ: QNTM) surged +10.8% to $4.30 on September 24, defying a weak biotech tape, after its licensee Unbuzzd Wellness named...
🟢 Quantum BioPharma is trading 10.8% up today after licensee Unbuzzd Wellness appointed Michael Zapolin CEO
Quantum BioPharma is trading at $4.30, up 10.82%, with Unbuzzd Wellness’s CEO appointment appearing to be the clearest company-specific catalyst. - The...
🟢 Quantum BioPharma is trading 5.7% up today amid reported premarket sector strength
Quantum BioPharma is trading 5.71% higher at $4.10, with sector-related strength reported in premarket trading. - A September 24 announcement said licensee...
🟢 Quantum BioPharma is trading 5% up in pre-market as biotech ETF XBI gains
Quantum BioPharma is trading 5.15% higher at $4.08, with the move appearing primarily sector-driven as biotech ETF XBI rises pre-market. - Shares are up from...